Form 483

Fresenius Kabi Austria Form 483, 2017-03-17

FDA issued a Form 483 to Fresenius Kabi Austria on 2017-03-17 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Fresenius Kabi Austria · Graz, Austria · Issued March 17, 2017

Overview

  • 6 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Mar 2017
21 CFR 123.9(f)

Computerized records

Cited by Massoud Motamed

17 Mar 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Massoud Motamed

17 Mar 2017
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Massoud Motamed

17 Mar 2017
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Massoud Motamed

17 Mar 2017
21 CFR 211.192

No written record of investigation

Cited by Massoud Motamed

Inspected site

FKFresenius Kabi AustriaGraz, Austria

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 123.9(f)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere